Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning

Bone Marrow Transplant. 2014 May;49(5):720-1. doi: 10.1038/bmt.2014.5. Epub 2014 Feb 3.

Authors

B Askaa¹, A Fischer-Nielsen², L Vindeløv¹, E K Haastrup², H Sengeløv¹

Affiliations

¹ Department Of Hematology, National University Hospital, Copenhagen, Denmark.
² Department of Clinical Immunology, National University Hospital, Copenhagen, Denmark.

PMID: 24488047
DOI: 10.1038/bmt.2014.5

No abstract available

Publication types

Letter

MeSH terms

Adult
Antigens, CD34 / metabolism
Delayed Graft Function / immunology
Delayed Graft Function / mortality
Delayed Graft Function / therapy*
Female
Hematopoietic Stem Cell Transplantation / adverse effects*
Hematopoietic Stem Cell Transplantation / mortality
Humans
Male
Middle Aged
Retrospective Studies
T-Lymphocytes / immunology
T-Lymphocytes / metabolism
T-Lymphocytes / transplantation*
Transplantation Chimera
Transplantation Conditioning
Transplantation, Homologous
Young Adult

Substances

Antigens, CD34